Buprenorphine Hydrochloride 70518-4570
Product NDC
70518-4570- Manufacturer
- Remedyrepack Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- February 10, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA090279
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
30 POUCH in 1 BOX (70518-4570-0) / 1 TABLET in 1 POUCH (70518-4570-1)